Good Start Genetics Announces Newest Launch of Next-Generation Embryo Screening Product

Proprietary Offering Brings Greater Affordability for Best-in-Class
Technology for Fertility Populations Globally

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Good Start Genetics, Inc., a family genetics information solutions
company, announced today the availability of an even more advanced
embryo screening offering, with greater affordability for patients,
based on its own proprietary sequencing platform and technology
exclusively licensed from Johns Hopkins University. This enhanced
version of EmbryVu, the company’s preimplantation genetic
screening (PGS) test, has been developed to enable detection of
segmental aneuploidies, in addition to whole chromosome gain or loss.
Because EmbryVu helps fertility specialists select embryos for
transfer that have a normal chromosome complement, it is expected to
significantly increase the chances of a successful pregnancy following
IVF.

“Given the global market opportunity for PGS and the need for better
embryo screening at affordable prices, we intend to continue to invest
in this very important product area to help even more IVF customers
further improve pregnancy rates with the best technologies at prices
they can afford,” said Jeffrey Luber, president and chief executive
officer of Good Start Genetics. “We will continue to pursue other
genetic testing areas where our scientific lead, cost advantages, and
national footprint can have broad impact.”

This enhanced version of EmbryVu is available through IVF centers
across the country, including IVF centers in the state of New York where
the company recently received approval for its newest release.

About Good Start Genetics®, Inc.
Good Start Genetics is an
information solutions company delivering best-in-class genetics
offerings to growing families. Using advanced clinical sequencing,
proprietary methods and information tailored to the individual, the
Company’s suite of offerings arms clinicians and patients with
insightful and actionable information to promote successful pregnancies
and help build healthy families. Its flagship genetic carrier screening
service, GeneVu™, is a comprehensive menu of highly-accurate tests for
known and novel mutations that cause inherited genetic disorders, and
its proprietary and advanced preimplantation genetic screening test,
EmbryVu™, based on technologies exclusively licensed from Johns Hopkins
University School of Medicine, is helping a wider range of couples find
their paths to pregnancy at significantly lower costs. Good Start
Genetics complements these offerings with world- class customer care and
genetic counseling to help families stay well-informed and best prepare
for tomorrow. For more information, please visit www.goodstartgenetics.com
or join us on Facebook, Twitter and LinkedIn.

Contacts

Good Start Genetics, Inc.
Marc Jones, 617-714-0815
mjones@gsgenetics.com